Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-03 · accession 0001437749-22-010926 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-04 | 2022-05-03 | PBYI | NOUGUES MAXIMO F | CFO | S - Sale | $2.34 | -165 | 121.2K | -0.1% | -$386.10 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-03 | S | D | 165 | $2.34 | 121,228 | D | — | — |